SUMMARY It is generally believed that preoperative iodide decreases the hyperplasia of the toxic thyroid gland. Histometric studies of glands from thyrotoxic patients pretreated with propranolol alone compared with those from patients pretreated with propranolol and iodide failed to confirm this. Although histological appearances and volume percentage measurement of component tissues suggested that the glandular epithelium had involuted after iodine treatment, measurement of their absolute mass indicated that the mean mass of epithelium was the same in both groups and that involution had not occurred. We conclude that considerable confusion in the thyroid literature has arisen through incorrect use of the term involution.
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The histology of the untreated thyrotoxic gland has been well documented (Marine and Lenhart, 1911; Wegelin, 1926) but is now rarely seen. Iodide is widely believed to induce involution by reducing the hyperplasia (Green, 1971; Meissner, 1971; Ingbar and Woeber, 1974) and vascularity (Rienhoff, 1925) of the toxic gland, and several authors have used the fall in epithelial cell height as a measure of involution (Rawson and McArthur, 1947; Sommers, 1968) . Properly defined, involution means the shrinkage of an organ towards its original size (Butterworth's Medical Dictionary, 1965) and implies a reduction in cellular content (Dorland's Medical Dictionary, 1974) .
Thyroid stimulating immunoglobulins (TSI) have been found in all patients with untreated Graves' disease, and this antibody is strongly implicated as a cause of the hyperthyroidism (Mukhtar et al., 1975) . The half-life of TSI is presumably the same as that of IgG (15-20 days) and it seems improbable that TSI levels could be influenced by a 10-day preoperative course of iodide. It is therefore pertinent to question whether involution of thyroid tissues can occur at a time when TSI stimulation persists. The purpose of this investigation is to test the hypothesis that iodide induces involution by determining histometrically whether the size and cellular content of thyroids from Received for publication 15 June 1976 thyrotoxic patients treated with propranolol and iodide differs from that of patients treated with propranolol alone.
Patients and methods
Two groups of patients were studied. The first (group 1) received propranolol, 160 mg daily, for periods of up to six weeks before undergoing subtotal thyroidectomy, and the second (group 2) received 20 minims of Lugol's iodine (iodine with potassium iodide) thrice daily for the 10 days immediately before operation in addition to a similar course of propranolol. The patients were not selected and were drawn from two successive 18-month periods during which iodide was first included and then omitted from the preoperative regime. Group 1 comprised 38 patients, mean age 34-2 years, of whom 7 were male and 31 female. The mean age of the 32 patients in group 2 was 32-6 years; 5 were male and 27 female. There was no statistically significant difference in the age and sex distribution between the two groups.
A standard thyroidectomy was used throughout. Total gland mass was calculated from the weight of the resected specimen plus the estimated remnant. The errors involved in estimating the remnant mass are known to be small relative to the total gland mass (Hedley et al.. 1972) . Both diffusely toxic glands and multinodular toxic goitres were included in the study. (Young et al., 1975) and the mass of each was calculated from the product of its volume percentage and the total mass of the gland. The scalloped retraction spaces at the acinar margins of the colloid are fixation artefacts which are not present in life (Haley et al., 1955 (Rienhoff, 1925) . In addition, it is claimned that iodide brings about involution of the hyperplastic gland (Green, 1971 ). Propranolol does not appear to influence the function of the toxic thyroid gland (Hadden et aL., 1969) and is therefore unlikely itself to modify thyroid histology. (Fig. 2) . We have shown that iodide-treated glands contain almost twice as much colloid as those treated with propranolol alone. Furthermore, the iodised glands are for this reason correspondingly larger than those from group 1 patients, so that there appears to be no basis, either histometrically or anatomically, for the claim that iodide induces involution.
The thyroid gland is firmly encapsulated in cervical fascia. The rapid increase in its size which follows iodide administration might be expected to cause a temporary rise in intrathyroidal pressure, compensated by a reduction in volume of the vascular and lymphatic spaces. Such events might explain the firmness (Rienhoff, 1925) and diminished vascularity of the iodised gland (Green, 1971; Rienhoff, 1925) . Furthermore, the change in epithelial appearance from columnar to cuboidal during iodide administration is less likely to be an index of involution than an expression of the distortion which cells lining the follicle must inevitably undergo as it becomes distended with new colloid (Fig. 2) .
We conclude that considerable confusion in the thyroid literature has resulted in the past from incorrect use of the term involution which should be reserved for situations where an enlarged organ reverts towards its normal size by reduction in its cell mass (eg, postpartum uterus 
